Literature DB >> 18382130

Towards prediction of degenerate CTL epitope recognition.

Fusheng Li1, Denise M McKenney, Uma Malhotra, Claire Crimi, Jessica Nolin, Lawrence Corey, Juliana M McElrath, Mark J Newman, Steven G Self.   

Abstract

The cellular immune system is characterized by flexibility with respect to epitope recognition at the level of peptide binding to HLA molecules and HLA-peptide complexes to T-cell receptors (TCRs). For epitopes recognized by cytotoxic T-lymphocytes (CTLs), amino acid substitutions at different positions have varying impact on recognition. By analyzing the frequencies of specific amino acid substitutions at each position in conjunction with HLA-peptide binding and immune-response data, we have developed new methods to predict cross-reactive recognition of epitope variants by CTLs. We derived position-specific substitution matrices (EPSSMs) through the analysis of known HLA ligands and achieved relatively accurate prediction of detrimental and tolerated amino acid substitutions. Initial analysis of amino acid substitutions in CTL epitopes with degenerate recognition showed strong position-specific preferences. This first systematic analysis further suggested that spatial constraint may be the major molecular factor determining the degenerate epitope recognition. As the data cumulates, we anticipate that eventually EPSSMs will be available for prediction of degenerate T-cell epitope recognition.

Mesh:

Substances:

Year:  2007        PMID: 18382130     DOI: 10.4161/hv.4.2.5215

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  5 in total

Review 1.  Post-step modifications for research on HIV vaccines.

Authors:  Lawrence Corey; M Juliana McElrath; James G Kublin
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

2.  Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.

Authors:  Oksana Penezina; Neil X Krueger; Isaac R Rodriguez-Chavez; Michael P Busch; John Hural; Jerome H Kim; Robert J O'Connell; Eric Hunter; Said Aboud; Keith Higgins; Victor Kovalenko; David Clapham; David Crane; Andrew E Levin
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

3.  Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.

Authors:  David R Kaufman; Fusheng Li; Ashley N Cruz; Steven G Self; Dan H Barouch
Journal:  Vaccine       Date:  2011-11-29       Impact factor: 3.641

4.  A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.

Authors:  Matthew R Reynolds; Andrea M Weiler; Shari M Piaskowski; Michael Piatak; Henry T Robertson; David B Allison; Andrew J Bett; Danilo R Casimiro; John W Shiver; Nancy A Wilson; Jeffrey D Lifson; Wayne C Koff; David I Watkins
Journal:  Vaccine       Date:  2012-05-06       Impact factor: 3.641

5.  An HIV-1 Mini Vaccine Induced Long-lived Cellular and Humoral Immune Responses.

Authors:  Mehdi Mahdavi; Massoumeh Ebtekar; Zuhair Mohammad Hassan; Sobhan Faezi; Hamidreza Khorram Khorshid; Morteza Taghizadeh; Keyhan Azadmanesh
Journal:  Int J Mol Cell Med       Date:  2015
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.